StonvexLoading…
StonvexStonvexStonvexCore line items from ABCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.31M | $75.13M | $30.27M | $21.32M |
Operating Income | $-57.52M | $-217.10M | $-188.52M | $-112.25M |
Net Income | $-43.16M | $-146.41M | $-137.47M | $-34.73M |
EPS (Diluted) | $-0.14 | $-0.49 | $-0.46 | $-0.27 |
Total Assets | $1.31B | $1.36B | $1.36B | $1.40B |
Total Liabilities | $369.03M | $390.05M | $391.95M | $394.99M |
Cash & Equivalents | $77.06M | $128.51M | $83.16M | $92.44M |
Free Cash Flow OCF − CapEx | $-37.35M | $-174.07M | $-129.48M | $-67.96M |
Shares Outstanding | 303.95M | 300.60M | 299.01M | 295.76M |